News & Events

• September 12, 2023
  

  C-Path’s Rare Disease Clinical Outcome Assessment Consortium Launches Rare Disease COA Resource

  The Rare Disease COA Resource aims to simplify COA selection for use in rare disease drug development.   TUCSON, Ariz., September 12, 2023 — The Rare Disease Clinical Outcome Assessment (COA) Consortium at Critical Path Institute (C-Path), a public-private partnership focused on optimizing COA selection during drug development for rare diseases, today announced the launch...
• September 11, 2023 - September 13, 2023
  

  2023 Rare and Orphan Disease Conference presented by C-Path

    Patients, providers, researchers, clinicians, biopharmaceutical companies, regulatory reviewers and scientists will leave this 2.5-day conference with an understanding of: C-Path’s Rare and Orphan Disease Program’s current and future impact on drug development in rare diseases The Critical Path for Rare Neurodegenerative Diseases (CP-RND) initiative’s first year impact and highlights How RDCA-DAP has been enhanced...
• August 30, 2023
  

  NIDDK Central Repository 20th Anniversary Workshop: Promoting Secondary Research to Accelerate Medical Breakthroughs and Innovation

  The National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) workshop highlights secondary use research that utilized resources generated from NIDDK-funded clinical research projects. The event also offers a review of NIDDK’s Data Ecosystem past, present, and future and launches a data challenge platform as part of the program’s vision for the future. C-Path’s T1D...
• August 30, 2023
  

  Fall 2023 HRA Members Meeting

  This October 16-17, in Chicago, IL members of C-Path’s CDRC team will join the Health Research Alliance’s Members Meeting. The Health Research Alliance is a collaborative member organization of nonprofit research funders committed to maximizing the impact of biomedical research to improve human health. CDRC Senior Scientific Director Smith Heavner, will present on repurposing treatments...
• August 29, 2023
  

  Externally-Led Patient Focused Drug Development

  C-Path’s Polycystic Kidney Disease Outcomes Consortium (PKDOC) and the PKD Foundation will be hosting an Externally-Led Patient Focused Drug Development (EL-PFDD) meeting for Autosomal Recessive Polycystic Kidney Disease (ARPKD) on Tuesday, August 29th.  EL-PFDD meetings bring together patients and care partners, US Food and Drug Administration (FDA) representatives, pharmaceutical companies, physicians, and researchers who are...